¶ÈÀÓ¾Ò²ð

2021ǯ

¸¶ÃøÏÀʸ¡¿¾ÉÎãÊó¹ð

  1. Mitsukuni Murasaki, Yoshifumi Inoue, Hiroshi Nakamura, Toshihiko Kinoshita ; Long-term oral blonanserin treatment for schizophrenia: a review of Japanese long-term studies ; Annals of General Psychiatry ; 20 ¡Ê1¡Ë : 1-11
  2. Yoshiteru Takekita, Shuichi Hiraoka, Yasuhiro Iwama, Naotaka Sunada, Nobuatsu Aoki, Haruhiko Ogata, Toshiya Funatsuki, Chikashi Takano, Tomoyo Yanagida, Yosuke Koshikawa, Minami Naito, Atsuko Yamamoto, Masaki Kato, and Toshihiko Kinoshita ; Divergence of dose response with asenapine : a cluster analysis of randomized, double-blind, placebo control study ; CNS spectrums ; ¡Ê19¡Ë : 1-9
  3. Nobuatsu Aoki, Taro Suwa, Hirotsugu Kawashima, AranTajika, Naotaka Sunada, Toshiyuk iShimizu, Toshiya Murai, Toshihiko Kinoshita, Yoshiteru Takekita ; Sevoflurane in electroconvulsive therapy: A systematic review and metaanalysis of randomised trials ; Journal of Psychiatric Research ; ¡Ê141¡Ë : 16-25
  4. Masaki Kato, Hikaru Hori, Takeshi Inoue, Junichi Iga, Masaaki Iwata, Takahiko Inagaki, Kiyomi Shinohara, Hissei Imai, Atsunobu Murata, Kazuo Mishima, Aran Tajika ; Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis ; Molecular psychiatry ; 26 ¡Ê1¡Ë : 118-133
  5. Hitoshi Sakurai, Norio Yasui-Furukori, Takefumi Suzuki, Hiroyuki Uchida, Hajime Baba, Koichiro Watanabe, Ken Inada, Yuka Sugawara Kikuchi, Toshiaki Kikuchi, Asuka Katsuki, Ikuko Kishida, Masaki Kato ; Pharmacological Treatment of Schizophrenia: Japanese Expert Consensus ; Pharmacopsychiatry ; 54 ¡Ê2¡Ë : 60-67
  6. Hiroyoshi Takeuchi, Yoshiteru Takekita, Hikaru Hori, Kazuto Oya, Itaru Miura, Naoki Hashimoto, Norio Yasui-Furukori ; Pharmacological treatment algorithms for the acute phase, agitation, and maintenance phase of first-episode schizophrenia: Japanese Society of Clinical Neuropsychopharmacology treatment algorithms ; Hum Psychopharmaco ; 36 ¡Ê6¡Ë : 1-9
  7. Keiichiro Nishida, Yosuke Morishima, Roberto D. Pascual- Marqui, Shota Minami, Tomonari Yamane, Masahito Michikura, Hideki Ishikawa , Toshihiko Kinoshita ; Mindfulness augmentation for anxiety through concurrent use of transcranial direct current stimulation: a randomized double-blind study ; scientific reports ; 11 ¡Ê1¡Ë : 1-12
  8. Masataka Shinozaki, Norio Yasui-Furukori, Naoto Adachi, Hitoshi Ueda, Seiji Hongo, Takaharu Azekawa, Yukihisa Kubota, Eiichi Katsumoto, Koji Edagawa, Eiichiro Goto, Kazuhira Miki, Masaki Kato, Atsuo Nakagawa, Toshiaki Kikuchi, Takashi Tsuboi, Koichiro Watanabe, Kazutaka Shimoda, Reiji Yoshimura ; Differences in prescription patterns between real-world outpatients with bipolar I and II disorders in the MUSUBI survey ; Asian Journal of Psychiatry ; 67:1-6
  9. Naoto Adachi , Takaharu Azekawa , Kouji Edagawa , Eiichiro Goto , Seiji Hongo , Masaki Kato , Eiichi Katsumoto , Toshiaki Kikuchi , Yukihisa Kubota , Kazuhira Miki , Atsuo Nakagawa, Takashi Tsuboi , Hitoshi Ueda , Koichiro Watanabe , Yoichiro Watanabe , Norio Yasui-Furukori , Reiji Yoshimura ; Estimated model of psychotropic polypharmacy for bipolar disorder: Analysis using patients' and practitioners' parameters in the MUSUBI study ; Hum Psychopharmacol ; 36 ¡Ê2¡Ë :1-8
  10. Yusuke Konno , Yoshihisa Fujino , Atsuko Ikenouchi , Naoto Adachi , Yukihisa Kubota , Takaharu Azekawa , Hitoshi Ueda, Koji Edagawa , Eiichi Katsumoto , Eiichiro Goto , Seiji Hongo , Masaki Kato , Takashi Tsuboi , Norio Yasui-Furukori, Atsuo Nakagawa , Toshiaki Kikuchi , Koichiro Watanabe , Reiji Yoshimura ; Relationship Between Mood Episode and Employment Status of Outpatients with Bipolar Disorder: Retrospective Cohort Study from the Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Clinics ¡ÊMUSUBI¡Ë Project ; Neuropsychiatric Disease and Treatment ; 17 : 2867-2876
  11. Oliver Pain, Karen Hodgson, Vassily Trubetskoy, Stephan Ripke, Victoria S. Marshe, Mark J.Adams, Enda M. Byrne, Adrian I. Campos, Tania Carrillo-Roa, Annamaria Cattaneo, Thomas D. Als, Daniel Souery, Mojca Z. Dernovsek, Chiara Fabbri, Caroline Hayward, Neven Henigsberg, Joanna Hauser, James L. Kennedy , Eric J. Lenze , Glyn Lewis, Daniel J. Müller, Nicholas G. Martin, Benoit H. Mulsant, Ole Mors, Nader Perroud, David J. Porteous, Miguel E. Rentería, Charles F. Reynolds,Marcella Rietschel, Rudolf Uher, Eleanor M.Wigmore, Wolfgang Maier, Naomi R.Wray, Katherine J. Aitchison, Volker Arolt, Bernhard T. Baune, Joanna M. Biernacka, Guido Bondolfi, Katharina Domschke, Masaki Kato,Qingqin S. Li, Yu-Li Liu, Alessandro Serretti, Shin- Jen Tsai, Gustavo Turecki, Richard Weinshilboum, the GSRD Consortium, the Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Andrew M. Mclntosh, and Cathryn M. Lewis ; Identifying the Common Genetic Basis of Antidepressant Response ; Biological Psychiatry Global Open Science ; 1-12
  12. ¿ÛˬÂÀϺ, °ÂÅÄϹ¬, ÀîÅç·¼»Ì, ÀÄÌÚÀëÆÆ, Æâ¾ÂÆú°áºÚ, ÖÖË̲µ±, ÏÂÅÄ·ò ; Åŵ¤¤±¤¤¤ì¤óÎÅË¡¤Ë¤ª¤±¤ëȯºîͶȯº¤ÆñÎã¤È200%µ¡´ï¤Ë¤Ä¤¤¤Æ ¡½ÂбþË¡¤Ë´Ø¤¹¤ë¸½¶·Ä´ºº¤Èʸ¸¥¥ì¥Ó¥å¡¼¡½ ; Áí¹çɱ¡Àº¿À°å³Ø ; 33 ¡Ê3¡Ë : 286-297
  13. Ë̸µ·ò, ¶¶Ëܾ»Ì÷, µÈ±ÊÍÛ»Ò ; DuloxetineÅêÍ¿¸å¤ËÄãNa·ì¾É¤ò¤­¤¿¤·SIADH¤È¿ÇÃǤ·¤¿1¾ÉÎã ; Î×¾²Àº¿ÀÌôÍý ; 24 ¡Ê9¡Ë : 969-973

¥Ú¡¼¥¸TOP¤ØÌá¤ë

ÁíÀ⡦²òÀ⡦¤½¤Î¾

  1. µÈ¼¶©»Ë, Ë̱ºÍ´°ì, ÖÖË̲µ±, çÕÄеªÌé, ÆîæÆÂÀ, ÇðÌÚÍÛ²ð, ÌÚ²¼Íøɧ ; ǧÃξɴµ¼Ô¤Ë¤ª¤±¤ëºÇ¿·¤Î¤»¤óÌÑÂкö ; Àº¿À²Ê¼£ÎÅ³Ø ; 36 ¡Ê12¡Ë : 49-53
  2. µÈ¼¶©»Ë ; ¡Ê´¬Æ¬¸À¡Ë ¹âÎð´µ¼Ô, ǧÃξɴµ¼Ô¤Èºî¶ÈÎÅË¡ ; ϷǯÀº¿À°å³Ø»¨»ï 32 ¡Ê12¡Ë : 1251-1252
  3. ²ÃÆ£Àµ¼ù ; ¹³¤¦¤ÄÌô¤Î½Ð¸ýÀïά-¥·¥¹¥Æ¥Þ¥Æ¥£¥Ã¥¯¥ì¥Ó¥å¡¼¤Îdicisionaid¤Î³µÍ× ; Î×¾²Àº¿ÀÌôÍý ; 24 ¡Ê9¡Ë : 929-936
  4. ²ÃÆ£Àµ¼ù ; ¤¦¤ÄÉ¤Υ¨¥­¥¹¥Ñ¡¼¥È¥³¥ó¥»¥ó¥µ¥¹¤Ë¤è¤ëÌôʪÎÅË¡¤Î¹Í¤¨Êý¤È¼ÂÁ© ; Depression Strategy ; Áý´©¹æ : 4-8
  5. ²ÃÆ£Àµ¼ù, ¿·ÄÅÉÙ±û, ¾¾ËܾÍɧ, ÖÖË̲µ± ; ¥¤¥¿¥ê¥¢¡¦¥Ü¥í¡¼¥Ë¥ãÂç³Øα³Ø¤Î¤¹¡µ¤á ; Àº¿À²Ê ; 39 ¡Ê3¡Ë : 319-326
  6. ÖÖË̲µ±, ÌÚ²¼Íøɧ ; LAI ¼£ÎŤο·¤¿¤ÊŸ³« ; Î×¾²Àº¿ÀÌôÍý ; 24 ¡Ê11¡Ë : 1079-1087
  7. °ðÅÄ·ò, ¶âÂôŰʸ, ´ßËÜÂÙ»ÎϺ, ÃÝÆâ·¼Á±, ÖÖË̲µ±, ë±ÑÌÀ, îëÀº°ìϺ, ÆÁÁýÂ, ¶¶ËÜľ¼ù, ¾¾°æ·òÂÀϺ, »³ÅĹÀ¼ù ; ¸þÀº¿ÀÌô¤Î½Ð¸ýÀïά- ¹³Àº¿ÀÉÂÌô ; Î×¾²Àº¿ÀÌôÍý ; 24 ¡Ê9¡Ë : 919-927
  8. ÃÓÅĽӰìϺ, ÆîæÆÂÀ, ÄÑËüΤ ; rTMS¤Î¾¤ÎÀº¿À¼À´µ¤Ø¤ÎŬ±þ ; ºÇ¿·Àº¿À°å³Ø ; 26 ¡Ê5¡Ë : 401-406
  9. ¿¥ÅÄ͵¹Ô ; Æý¸¡¡ED ¿ÇÎŤΥեí¥ó¥È¥é¥¤¥ó- ¤³¤Î°ìºý¤Ç´Ý¤ï¤«¤ê! ¡Ö¥á¥ó¥¿¥ë¥Ø¥ë¥¹¤ÈED¡× ; Î×¾²ÈçÇ¢´ï²Ê¡Ê°å³Ø½ñ±¡¡Ë ; 75 ¡Ê9¡Ë : 622-625
  10. ¿¥ÅÄ͵¹Ô ; °åÎÅ¥¹¥¿¥Ã¥Õ¤¬ÃΤäƤª¤­¤¿¤¤À­Åª¥Þ¥¤¥Î¥ê¥Æ¥£¤È°åÎÅ ¡ÖÃÏ°è¤Ë¤ª¤±¤ë¿»ÜÀßÏ¢·È¤«¤é¶¨Æ¯¤Ø¤Î¿ÊŸ¡× ; °å³Ø¤Î¤¢¤æ¤ß ; 279 ¡Ê4¡Ë : 273-277
  11. ¿¥ÅÄ͵¹Ô ; ¥Û¥ë¥â¥óÎÅË¡¤Î¸ú²Ì¤ËÂФ¹¤ë¿´ÍýŪɾ²Á ; ÆüËÜÀ­²Ê³Ø²ñ»¨»ï ; 39 ¡Ê1¡Ë : 85
  12. ÀÄÌÚÀëÆÆ, ÖÖË̲µ±, À¾ËÜÂç¼ù, ÌÚ²¼Íøɧ ; ECT¤Î¸½¾õ¤È´üÂÔ ; ºÇ¿·Àº¿À°å³Ø ; 26 ¡Ê5¡Ë : 407-417
  13. ½ïÊý¼£É§, ÖÖË̲µ±, ²ÃÆ£Àµ¼ù ; Åý¹ç¼ºÄ´¾É´µ¼Ô¤ËÂФ¹¤ë¹³Àº¿ÀÉÂÌô¼£ÎŤˤª¤±¤ëÌôºÞÀ­¿íÂγ°Ï©¾É¾õ¤Ë´Ø¤ï¤ëpharmacogenetics ; Î×¾²Àº¿ÀÌôÍý ; 24 ¡Ê2¡Ë : 135-143
  14. çÕÄеªÌé, ²ÃÆ£Àµ¼ù ; ¹âÎð¼Ô¤Î¤¦¤ÄɤËÂФ¹¤ëÌôʪÎÅË¡ ; ϷǯÀº¿À°å³Ø»¨»ï 32 ¡Ê12¡Ë : 1288-1297
  15. À¶¿åÉÒ¹¬, ÌÚ²¼Íøɧ, ÖÖË̲µ± ; »ý¸úÀ­Ãí¼ÍºÞ¤Î¼Ò²ñŪÇطʤȺ£¸å¤ÎŸ˾ ; Î×¾²Àº¿À°å³Ø ; 50 ¡Ê10¡Ë : 1069-1075
  16. À¶¿åÉÒ¹¬, ÌÚ²¼Íøɧ, ÖÖË̲µ± ; Àº¿À²Ê¤Ç»ÈÍѤµ¤ì¤ë½ùÊüºÞ¤ÎÆÃħ ; Î×¾²Àº¿ÀÌôÍý ; 24 ¡Ê6¡Ë : 589-596
  17. ¼À¥Íº»Î, ÌÚ²¼Íøɧ, ÖÖË̲µ± ; Åý¹ç¼ºÄ´¾É¼£ÎŤˤª¤±¤ë¥ë¥é¥·¥É¥ó±ö»À±ö¤Î°ÌÃ֤Ť± ; Àº¿À²Ê ; 38 ¡Ê6¡Ë : 746-754
  18. ¼À¥Íº»Î, ²ÃÆ£Àµ¼ù ; ÁжËÀ­¾ã³²¼£ÎŤˤª¤±¤ëaripiprazoleÆøúÀ­Ãí¼ÍºÞ¤Î°ÂÁ´À­¤Èµ¡Ç½²óÉü¤Ë²Ì¤¿¤¹Ìò³ä ; Î×¾²Àº¿À ÌôÍý ; 24 ¡Ê11¡Ë : 1097-1105
  19. ±ÛÀîÍÛ²ð ; COVID-19 ή¹Ô²¼¤Ë¤ª¤±¤ë¥ª¥ó¥é¥¤¥ó¡¦¥«¥¦¥ó¥»¥ê¥ó¥°¤Î¸½¾õ¤ÈƳÆþ¤Ë¤ª¤±¤ë²ÝÂê ; ¿À¸Í³Ø±¡Âç³Ø¿´ÍýÎ×¾²¥«¥¦¥ó ¥»¥ê¥ó¥°¥»¥ó¥¿¡¼µªÍ× 14 : 11-16
  20. ±ÛÀîÍÛ²ð ; ¥á¥ó¥¿¥ë¥Ø¥ë¥¹¤Ë¤ª¤±¤ë̤ɤȲðÆþÀïά¤Ø¤Î²ÄǽÀ­¤Î¸¡Æ¤ ; ÆüËṲ̈ɳزñ»¨»ï 27 ¡Ê3¡Ë : 58-62
  21. ²Ïùõ½ÓÇî, ±ÛÀîÍÛ²ð, ÅÄÃ潨ÃË, Åû°æÍ¥²ð ; ¥³¥í¥Ê²Ò¤Ë¤ª¤±¤ëÉ԰¤ËÂФ¹¤ë¥Õ¥©¡¼¥«¥·¥ó¥°¤Î³èÍѤȰյÁ ; ÄɼêÌç³Ø±¡Âç³ØÃÏ°è»Ù±ç¿´Íý¸¦µæ¥»¥ó¥¿¡¼Éí° ¿´¤ÎÁêÃ̼¼µªÍ× 17 : 12-22
  22. ÃæÀî͵Èþ, ÃÝÅĹä, ±ÛÀîÍÛ²ð, ²¬Â¼¿´Ê¿ ; ¥³¥í¥Ê²Ò¤Î¥Æ¥ì¥ï¡¼¥¯¤ª¤è¤Ó»Å»ö¤È²ÈÄí¤Î¶­³¦´ÉÍý¤¬¥ï¡¼¥¯¡¦¥Õ¥¡¥ß¥ê¡¼¡¦¥Ð¥é¥ó¥¹¤ËÍ¿¤¨¤ë±Æ¶Á ; »º¶È¡¦ÁÈ¿¥¿´Íý³Ø¸¦µæ 35 ¡Ê1¡Ë : 165-178
  23. ¹âÌî½à, ÌÚǼ½á°ì ; ¥¹¥Ý¡¼¥Ä¤Ë¤è¤ëǧÃε¡Ç½²þÁ±¤Î²ÄǽÀ­ ; Àº¿À²Ê ; 38 ¡Ê4¡Ë : 416-423

¥Ú¡¼¥¸TOP¤ØÌá¤ë

Ãø½ñ

  1. µÈ¼¡¡¶©»Ë ; ºÇ¶á¤ÎÄêÎÌǾÇȲòÀϼêË¡ ; Ëã¿ì¡¦½¸Ãæ¼£ÎŤȥƥ¯¥Î¥í¥¸¡¼2020 ; 1-4 ÆüËÜËã¿ì¡¦½¸Ãæ¼£Îťƥ¯¥Î¥í¥¸¡¼³Ø²ñ,2021
  2. ²ÃÆ£Àµ¼ù ; ­·Ìôʪ¼£ÎųسÆÏÀ ­· -2 ¹³¤¦¤ÄÌô¤È¹³ÉÔ°ÂÌô 1, ¹³¤¦ ¤ÄÌô¡¡¡ÊISBN : 9784791110742¡Ë ; ÀìÌç°å¤Î¤¿¤á¤ÎÎ×¾²Àº¿À¿À·ÐÌôÍý³Ø¥Æ¥­¥¹¥È ; ½éÈÇ¡Ê1¡Ë 186-195 À±Ï½ñŹ, 2021
  3. ²ÃÆ£Àµ¼ù¡¡; Âè5¾Ï Àº¿À¡¦¿À·Ð·Ï¤Î´ðËÜÌô¤Î»È¤¤Ê¬¤±¤¦¤ÄɤؤÎSSRI, SNRI, NaSSA, SRIM ¤Ï¤É¤¦Áª¤Ö?¡¡;¡¡·î´©Ìô»ö¡¡5·îÎ×»þÁý´©¹æ¡¡Æ±¼ï¡¦Æ±¸úÌô¤Î»È¤¤Ê¬¤±¡¡¼À´µ×´ðËÜÌô¤Î¥¨¥Ó¥Ç¥ó¥¹¤òÀ°Íý¤¹¤ë¡¡;¡¡63 ¡Ê7¡Ë 224-232 ¤¸¤Û¤¦, 2021
  4. ÖÖË̲µ± ; ­·Ìôʪ¼£ÎųسÆÏÀ ­· -5 ¾¤ÎÌôʪ, ¼£ÎÅ 1 ǧÃε¡Ç½²þÁ±Ìô¡¡¡ÊISBN : 9784791110742¡Ë¡¡; ÀìÌç°å¤Î¤¿¤á¤ÎÎ×¾²Àº¿À¿À·ÐÌôÍý³Ø¥Æ¥­¥¹¥È ; ½éÈÇ¡Ê1¡Ë 239-250 À±Ï½ñŹ, 2021
  5. ÖÖË̲µ±, °ÂÅÄϹ¬, ÀÄÌÚÀëÆÆ, ÎëÌÚ·òʸ, ÌÚ²¼Íøɧ ; ­· Ìô¼£ÎųسÆÏÀ ­·-5 ¾¤ÎÌôʪ, ¼£ÎÅ 4 Åŵ¤¤±¤¤¤ì¤óÎÅË¡¡¡¡ÊISBN : 9784791110742¡Ë ; ÀìÌç°å¤Î¤¿¤á¤ÎÎ×¾²Àº¿À¿À·ÐÌôÍý³Ø¥Æ¥­¥¹¥È ; ½éÈÇ¡Ê1¡Ë 268-278 À±Ï½ñŹ, 2021
  6. À¾ÅÄ·½°ìϺ[ ¤Û¤«] ¡ÊÆüËÜÎ×¾²¿À·ÐÀ¸Íý³Ø²ñ¡¡Ç¾»É·ãË¡¤Ë´Ø¤¹¤ë¾®°Ñ°÷²ñ¡Ë ; Ä㶯ÅÙ·ÐƬ³¸Åŵ¤»É·ã¤Î°ÂÁ´À­¤Ë´Ø¤¹¤ë¥¬¥¤¥É¥é¥¤¥ó¡Ê2019 ǯÅÙºîÀ®ÈÇ¡Ë ; Î×¾²¿À·ÐÀ¸Íý³Ø ; 49 ¡Ê2¡Ë 109- 113 °ìÈ̼ÒÃÄË¡¿ÍÆüËÜÎ×¾²¿À·ÐÀ¸Íý³Ø²ñ,2021

¥Ú¡¼¥¸TOP¤ØÌá¤ë

2020ǯ

¸¶ÃøÏÀʸ¡¿¾ÉÎãÊó¹ð

  1. Yoshitaka Kawashima, Naohiro Yonemoto, Chiaki Kawanishi, Kotaro Otsuka, Masaru Mimura, Yasushi Otaka, Kazuya Okamura, Toshihiko Kinoshita, Osamu Shirakawa, Reiji Yoshimura, Nobuaki Eto, Satoshi Hashimoto, Hirokazu Tachikawa, Taku Furuno, Tatsuya Sugimoto, Katsumi Ikeshita, Masatoshi Inagaki, Mitsuhiko Yamada ; Two-day assertive-case-management educational program for medical personnel to prevent suicide attempts : A multicenter prepost observational study ; Psychiatry and clinical neurosciences ; 74(6):362-370
  2. Masaki Kato, Naoto Adachi, Yukihisa Kubata, Takaharu Azekawa, Hitoshi Ueda, Kouji Edagawa, Eiichi Katsumoto, Eiichiro Goto, Seiji Hongo, Takashi Tsuboi, Norio Yasui-Furukori, Reiji Yoshimura, Atsuo Nakagawa, Toshiaki Kikuchi, Toshihiko Kinoshita, Youichiro Watanabe, Kazuhira Miki, Koichiro Watanabe ; Clinical features related to rapid cycling and one-year euthymia in bipolar disorder patients : A multicenter treatment survey for bipolar disorder in psychiatric clinics(MUSUBI) ; Journal of psychiatric research ; 131:228-234
  3. Yoshinobu Matsuda, Hitoshi Tanimukai, Shinichiro Inoue, Shuji Inada, Koji Sugano, Hideaki Hasuo, Masafumi Yoshimura, Saho Wada, Chikako Dotani, Hiroyoshi Adachi, Yoshiaki Okamoto, Mari Takeuchi, Daisuke Fujisawa, Jun Kako, Chiyuki Sasaki, Yasuhiro Kishi, Nobuya Akizuki, Masatoshi Inagaki, Yosuke Uchitomi, Eisuke Matsushima, Toru Okuyama; JPOS/JASCC clinical guidelines for delirium in adult cancer patients : a summary of recommendation statements ; Japanese Journal of clinical Oncology ; 50(5):586-593
  4. Hitoshi Sakurai, Hiroyuki Uchida, Masaki Kato, Takefumi Suzuki, Hajime Baba, Koichiro Watanabe, Ken Inada, Toshiaki Kikuchi, Asuka Katsuki, Ikuko Kishida,Yuka Sugawara Kikuchi ,Norio Yasui-Furukori; Pharmacological management of depression : Janese expert consensus ; Jourmal of affective disorders ; 266:626-632
  5. Takashi Tsuboi, Takefumi Suzuki, Takaharu Azekawa, Naoto Adachi, Hitoshi Ueda, Kouji Edagawa, Eiichi Katsumoto, Yukihisa Kubota, Eiichiro Goto, Seiji Hongo, Yoichiro Watanabe, Masaki Kato, Norio Yasui,-Furukori, Reiji Yoshimura, Atsuo Nakagawa, Toshiaki kikuchi, Koichiro Watanabe ; Factors Associated with Non-Remission in Bipolar Disorder. The Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics(MUSUBI) ; Neuropsychiatric disease and treatment ; 31(16):881-890
  6. Hitoshi Sakurai, Masaki Kato, Norio Yasui-Furukori, Takefumi Suzuki, Hajime Baba, Koichiro Watanabe, Ken Inada, Ikuko Kishida, Yuka Sugawara Kikuchi, Toshiaki Kikuchi, Asuka Katsuki, Hiroyuki Uchida, Medical Education Panel of the Japanese Society of Clinical Neuropsychopharmacology ; Pharmacological management of bipolar disorder : Japanese expert consensus ; Bipoiar disorders ; Online ahead of print
  7. Masaki Kato, Hikaru Hori, Takeshi Inoue, Junichi Iga, Masaki Iwata, Takahiko Inagaki, Kiyomi Shinohara, Hissei Imai, Atsunobu Murata, Kazuo Mishima, Aran Tajika ; Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder : a systematic review and meta-analysis ; Molecular psychiatry ; Online ahead of print
  8. Masaki Kato, Yuko Asami, Dalia B, Wajsbrot, Xuemei Wang, Matthieu Boucher, Rita Prieto, Elizabeth Pappadopulos ; Clustering patients by depression symptoms to predict venlafaxine ER antidepressant efficacy : Individual patient data analysis ; Journal of psychiatric research ; 129:160-167
  9. Naoto Adachi, Takaharu Azekawa, Kouji Edagawa, Eiichiro Goto, Seiji Hongo, Masaki Kato, Eiichi Katsumoto, Toshiaki Kikuchi, Yukihisa Kubota, Kazuhira Miki, Atsuo Nakagawa, Takashi Tsuboi, Hitoshi Ueda, Koichiro Watanabe, Yoichiro Watanabe, Norio Yasui-Furukori, Reiji Yoshimura ; Estimated model of psychotropic polypharmacy for bipolar disorder : Analysis using patients’ and practitioners’ parameters in the MUSUBI study ; Human psychopharmacology ; Online ahead of print
  10. Keita Tokumitsu, Norio Yasui-Furukori, Naoto Adachi, Yukihisa Kubota, Yoichiro Watanabe, Kazuhisa Miki, Takaharu Azekawa, Koji Edagawa, Eiichi Katsumoto, Seiji Hongo, Eiichiro Goto, Hitoshi Ueda, Masaki Kato, Reiji Yoshimura ; Real-world clinical features of and antidepressant prescribing patterns for outpatients with bipolar disorder ; Multicenter Study BMC Psychiatry ; 20(1):555
  11. Norio Yasui-Furukori, Naoto Adachi, Yukihisa Kubota, Takaharu Azekawa, Eiichiro Goto, Koji Edagawa, Eiichi Katsumoto, Seiji Hongo, Hitoshi Ueda, Kazuhisa Miki, Masaki Kato, Reiji Yoshimura, Atsuo Nakagawa, Toshiaki Kikuchi, Takashi Tsuboi, Koichiro Watanabe, Kazutaka Shimoda ; Factors Associated with Doses of Mood Stabilizers in Real-world Outpatients with Bipolar Disorder ; Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology ; 18(4):599-606
  12. Hitoshi Sakurai, Norio Yasui-Furukori, Takefumi Suzuki, Hiroyuki Uchida, Hajime Baba, Koichiro Watanabe, Ken Inada, Yuka Sugawara Kikuchi, Toshiaki Kikuchi, Asuka Katsuki, Ikuko Kishida, Masaki Kato ; Pharmacological Treatment of Schizophrenia : Japanese Expert Consensus ; Pharmacopsychiatry ; 54(2):60-67
  13. Yoshiteru Takekita, Sachie Inoue, Kenji Baba, Tadashi Nosaka ; Rehospitalization Risk of Receptor-Affinity Profile in Antipsychotic Drug Treatment : A Propensity Score Matching Analysis Using a Japanese Employment-Based Health Insurance Database ; Neuropsychiatric disease and treatment ; 16:2871-2879
  14. Yoshiteru Takekita, Shuichi Hiraoka, Yasuhiro Iwama, Naotaka Sunada, Nobuatsu Aoki, Haruhiko Ogata, Toshiya Funatsuki, Chikashi Takano, Tomoyo Yanagida, Yosuke Koshikawa, Minami Naito, Atsuko Yamamoto, Masaki Kato, and Toshihiko Kinoshita ; Divergence of dose response with asenapine : a cluster analysis of randomized, double-blind, placebo control study ; CNS spectrums ; Online ahead of print
  15. Reza Kazemi,Reza Rostami,Shouka Dehghan,Zahra Nasiri,Solmaz Lotfollahzadeh,Abed L. Hadipour,Sanaz Khomami,Ryouhei Ishii,Shunichiro Ikeda ; Alpha frequency rTMS modulates theta lagged nonlinear connectivity in dorsal attention network ; Brain Research Bulletin ; 162:271-281
  16. ¿¥ÅÄ͵¹Ô, »³ÅÄÈÞº»»Ò ; ÃËÀ­¹¹Ç¯´ü¤Î¥á¥ó¥¿¥ë¥Ø¥ë¥¹¤Ë´Ø¤¹¤ëʸ¸¥Åª¹Í»¡ ; ÆüËÜÀ­²Ê³Ø²ñ»¨»ï ; 38(1):55-61
  17. ÆîæÆÂÀ, º½Åľ°¹§, À¾ÅÄ·½°ìϺ, ÖÖË̲µ±, ÌÚ²¼Íøɧ ; ÁÔǯ´ü¤Ë½Ð¸½¤·¤¿Àº¿ÀÉÂÍ;ɾõ¤«¤é22q.11.2·ç˳¾É¸õ·²¤¬È½ÌÀ¤·¤¿°ìÎã ; ºÇ¿·Àº¿À°å³Ø ; 25(2):117-121
  18. ÅÄÃæÍ¥¼ù, ÀÄÌÚÀëÆÆ, ÖÖË̲µ±, ÌÚ²¼Íøɧ ; ¶µ¼¼¾ÉÎ㸡Ƥ²ñ(¥·¥ê¡¼¥º6)´²²ò°Ý»ýÌÜŪ¤Î¥é¥â¥È¥ê¥®¥ó¤Ë¤è¤ê¡¢Åŵ¤¤±¤¤¤ì¤óÎÅË¡¤Îȯºî¤Î¼Á¤¬Äã²¼¤·¤¿¼£ÎÅÄñ¹³À­Åý¹ç¼ºÄ´¾É¤Î1Îã ; ºÇ¿·Àº¿À°å³Ø ; 25(5):399-403
  19. ÃÓÅĽӰìϺ, ³°Â¼½ÓÍ´, ÌÚ²¼Íøɧ ; ÌôʪǾÇȸ¦µæ¤«¤é¤Î¾ÉÎãÊó¹ð(Æý¸ ¸¦µæ¤Î´ÑÅÀ¤«¤é¤ß¤¿¾ÉÎãÊó¹ð) ; Àº¿À²Ê ; 37(2):168-174
  20. óîÆ£¹¬»Ò ; Ãí°Õ·ç´Ù¡¦Â¿Æ°À­¾ã³²Åª¤Ê¦Ì̤¬ÌÀ¤é¤«¤Ë¤Ê¤êÆñ½Â¤·¤Æ¤¤¤ë¾ÉÎã ; Àº¿ÀʬÀÏŪÀº¿À°å³Ø ; 11:103-112

¥Ú¡¼¥¸TOP¤ØÌá¤ë

ÁíÀ⡦²òÀ⡦¤½¤Î¾

  1. ÄÑËüΤ, ÖÖË̲µ±, ÌÚ²¼Íøɧ ; ¥í¥Ê¥»¥ó¥Æ¡¼¥× : Blonanserin transdermal patch ; ºÇ¿·Àº¿À°å³Ø ; 25(3):209-215
  2. µÈ¼¶©»Ë, Ë̱ºÍ´°ì, ÌÚ²¼Íøɧ ; ¡ÚǺ¤Þ¤·¤¤¶ÉÌ̤ÇÌô¤ò¤É¤¦»È¤¦¡©¤»¤óÌÑÌôʪÎÅË¡¤Î¥ê¥¹¥¯¡¦¥Ù¥Í¥Õ¥£¥Ã¥È¡Û¼À´µ¡¦ÉÂÂÖÊ̤Τ»¤óÌÑÌôʪÎÅË¡ ǧÃÎ¾É ; ·î´©Ìô»ö(Pharmaceuticals Monthly) ; 62(8):1551-1555
  3. ÄÑËüΤ, ÖÖË̲µ±, ÌÚ²¼Íøɧ ; ¡Ú¥í¥Ê¥»¥ó¥Æ¡¼¥×¤Î´ðÁäÈÎ×¾²¡Û Blonanserin transdermal patch¤Î´ðÁÃ(²òÀâ/Æý¸);Àº¿À²Ê37(6):667-674
  4. ÄÑËüΤ, µÈ¼¶©»Ë, À¾ÅÄ·½°ìϺ ; ¤¦¤ÄÉ¡¦¤¦¤Ä¾õÂ֤ˤª¤±¤ë·ÐƬ³¸Ä¾Î®»É·ã¤Î¸ú²Ì ; Î×¾²Àº¿À°å³Ø ; 49(6):741-748
  5. °æ¾å¿¿°ìϺ, ë¸þ¿Î, ¾¾ÅÄǽÀë, ­Ω¹À¾Í, °ðÅĽ¤»Î, ²¬ËÜÄ÷¹¸, ¿ûÌÆó, ƲëÃιá»Ò, Ï¡Èø±ÑÌÀ, µÈ¼¶©»Ë, ÏÂÅĺ´ÊÝ, °ð³ÀÀµ½Ó, ±ü»³Å° ; ¤»¤óÌѤÎÎ×¾²¸¦µæ¤«¤é¤ß¤¿¾ÉÎãÊó¹ð ; Àº¿À²Ê;37(2):185-191
  6. ²ÃÆ£Àµ¼ù ; Àº¿À¼À´µ¤ÎÌôÍý°äÅÁ¸¦µæ¤Î¸½¾õ¤Èº£¸å¤ÎŸ˾(Æý¸ °äÅÁ¤ÈÀº¿À¼À´µ) ; °å³Ø¤Î¤¢¤æ¤ß ; 272(12):1206-1211
  7. ²ÃÆ£Àµ¼ù ; ǾÆâ¤Ç¤Î¸þÀº¿ÀÌô¤ÎµóÆ° ¸½¾õ¤È¶á̤Íè¤òŸ˾¤¹¤ë;Î×¾²ÌôÍý³Ø 23(4):347-357
  8. ²ÃÆ£Àµ¼ù ; 2017ǯÅÙ Î×¾²ÌôÍý¸¦µæ¿¶¶½ºâÃľ޳ؽѾ©Îå¾Þ ¸¦µæÀ®²ÌÊó¹ð ¥²¥Î¥ß¥¯¥¹¡Ý¥¨¥Ô¥²¥Î¥ß¥¯¥¹¡Ý¥¤¥ó¥Õ¥©¥Þ¥Æ¥£¥¯¥¹¤Ë¤è¤ë, Àº¿À²ÊÎΰè¤Ç¤Î¥×¥ì¥·¥¸¥ç¥ó¥á¥Ç¥£¥¹¥ó¤òÌܻؤ·¤¿Î×¾²ÌôÍý³ØŪ¸¦µæ -¤¦¤ÄɤθÄÊ̲½°åÎÅ-;Î×¾²ÌôÍý³Ø ; 51(4):213-219
  9. ²ÃÆ£Àµ¼ù ; ¡ÚÆý¸ ÁжËÀ­¾ã³²-ºÇ¿·¤Î¿ÇÃǤȼ£ÎÅ-¡ÛÁжËÀ­¾ã³²¤Î¼£ÎÅ ÁжËÀ­¾ã³²¤ÎÌôʪÎÅË¡ ÁжËÀ­¾ã³²¼£ÎŤˤª¤±¤ë¹³¤¦¤ÄÌô¤ÎÀ§Èó ; 78(10):1703-1709
  10. ½ïÊý¼£É§, ÖÖË̲µ±, ²ÃÆ£Àµ¼ù ; Åý¹ç¼ºÄ´¾É´µ¼Ô¤ËÂФ¹¤ë¹³Àº¿ÀÉÂÌô¼£ÎŤˤª¤±¤ëÌôºÞÀ­¿íÂγ°Ï©¾É¾õ¤Ë´Ø¤ï¤ë pharmacogenetics ; Î×¾²¿À·ÐÌôÍý ; 24(2):135-143
  11. ÖÖË̲µ±, ÅĶᰡÍö ; Î×¾²¤ËÌòΩ¤Ä´ðÁÃÌôÍý³Ø¤ÎÍѸì²òÀâÂè9²ó¥ß¥é¡¼¥¤¥á¡¼¥¸»î¸³ ; Î×¾²Àº¿ÀÌôÍý(Japanese Journal of Clinical Psychopharmacology) ; 23(7):713-714
  12. ÖÖË̲µ±, ÀÄÌÚÀëÆÆ ; ȯºî¤ò˸¤²¤Ê¤¤¤¿¤á¤ËÀº¿À²Ê°å¤¬ÃΤäƤª¤¯¤Ù¤­ECT¤ÎËã¿ì´ØÏ¢¼êµ»¤Î¥¨¥Ó¥Ç¥ó¥¹ ; Î×¾²Àº¿ÀÌôÍý ; 23(12):1177-1185
  13. ¿¥ÅÄ͵¹Ô ; ÃËÀ­¹¹Ç¯´ü¤ËÂФ¹¤ëÀº¿À²Ê°å¤Î»×¤¤ ; ÆüËÜÀ­²Ê³Ø²ñ»¨»ï ; 38(1):91-91
  14. ÄÑËüΤ, À¾ÅÄ·½°ìϺ ; ·ÐƬ³¸Ä¾Î®Åŵ¤»É·ã¤Ë¤è¤ë´¶¾ð¤Ø¤Î¸ú²Ì ; Ǿ¿À·ÐÆâ²Ê(¿À·ÐÆâ²Ê) ; 93(1):47-53
  15. ±ÛÀîÍÛ²ð, »³º¬ÎÑÌé;¿ÍÍÀ­¤¬µá¤á¤é¤ì¤ë¸½Âå¤ËɬÍפÊǽÎϤ˴ؤ¹¤ë¡½¹Í»¡:Û£Ë椵¤òÊú¤¨¤¿¾õ¶·¤òÀ¸¤­È´¤¯¤¿¤ánegative capability ¤Î²ÄǽÀ­. ; ¥µ¥¤¥³¥í¥¸¥¹¥È : ´ØÀ¾Âç³ØÎ×¾²¿´ÍýÀìÌ翦Âç³Ø±¡µªÍ× ; 10:39-49
  16. »³º¬ÎÑÌé, ±ÛÀîÍÛ²ð ; Person-Centered Approach¤«¤é¸«¤¿Negative Capability:Èó»Ø¼¨Åª¤Ê¥»¥é¥Ô¥¹¥È¤ÎÃæ¤Çµ¯¤­¤Æ¤¤¤ë¤³¤È ; ¥µ¥¤¥³¥í¥¸¥¹¥È : ´ØÀ¾Âç³ØÎ×¾²¿´ÍýÀìÌ翦Âç³Ø±¡µªÍ× ; 10:51-58
  17. ³Ñδ»Ê, ±ÛÀîÍÛ²ð, Ãæ°æÈþºÌ»Ò ; ¿´Íý±ç½õ¿¦¤Îself-development¤ò¹Í¤¨¤ë : ¿¦¶Èȯã¤Ë´Ø¤¹¤ëʸ¸¥¸¦µæ¤ª¤è¤Ó¼ÂÁ©¤òÄ̤¸¤Æ ; ´ØÀ¾Âç³Ø¿´ÍýÎ×¾²¥»¥ó¥¿¡¼µªÍ× ; 11:33-43
  18. ²Ïùõ½ÓÇî, ±ÛÀîÍÛ²ð, ÅÄÃ潨ÃË, Åû°æÍ¥²ð ; ¿ÍÀ¸100ǯ»þÂå¤Ë³è¤«¤¹¥Õ¥©¡¼¥«¥·¥ó¥°-²­Æì¥ï¡¼¥¯¥·¥ç¥Ã¥×¤Ç¤Î¼è¤êÁȤß- ; ´ØÀ¾Âç³Ø¿´ÍýÎ×¾²¥»¥ó¥¿¡¼µªÍ× ; 11:45-54

¥Ú¡¼¥¸TOP¤ØÌá¤ë

Ãø½ñ

  1. ²ÃÆ£Àµ¼ù ; µ¤Ê¬¾ã³²UPDATE -ÆñÉÂÀ­¤¦¤ÄɤÎŬÀÚ¤ÊÌôʪÎÅË¡¤ò¹Í¤¨¤ë ; Ê̺ý¡¦°å³Ø¤Î¤¢¤æ¤ß Ê̺ý 1 ; °å»õÌô½ÐÈÇ;78-84, 2020
  2. ÖÖË̲µ± (ÆüËÜÀº¿À¿À·Ð³Ø²ñ ECT¡¦£òTMSÅù¸¡Æ¤°Ñ°÷²ñ) ; Chapter­· ECT¤Î¼ÂÁ©¼êµ»7.¤±¤¤¤ì¤óÉÔȯ¤Ø¤ÎÂбþ¤È¼¡²ó»É·ãÀßÄê ; ECT¥°¥Ã¥É¥×¥é¥¯¥Æ¥£¥¹ °ÂÁ´¤Ç¸ú²ÌŪ¤Ê¼£ÎŤòÌܻؤ·¤Æ(ISBN:9784880027852) ; ¿·¶½°å³Ø½ÐÈǼÒ;193-206, 2020
  3. ÀÄÌÚÀëÆÆ, ÖÖË̲µ± (ÆüËÜÀº¿À¿À·Ð³Ø²ñ ECT¡¦£òTMSÅù¸¡Æ¤°Ñ°÷²ñ) ; Chapter­¶ECT ¤Î¼£Îŷײè 3. ECT¤Î¼£Îŷײè ÄÌ»»²ó¿ô,ÉÑÅÙ,»É·ã¾ò·ï¤Ê¤É ; ECT¥°¥Ã¥É¥×¥é¥¯¥Æ¥£¥¹ °ÂÁ´¤Ç¸ú²ÌŪ¤Ê¼£ÎŤòÌܻؤ·¤Æ(ISBN:9784880027852) ; ¿·¶½°å³Ø½ÐÈǼÒ;129-143, 2020

¥Ú¡¼¥¸TOP¤ØÌá¤ë